Investing Profile
Dan Becker
Your Intro Paths to Dan Becker
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Find Dan Becker on
cbCurrent Investing Position
Access Biotechnology Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
11
Dan Becker is on these Sector & Stage Rankings
Therapeutics (Series B)Therapeutics (Series B)Therapeutics (Series A)Therapeutics (Seed)Therapeutics (Series B)Therapeutics (Series A)Pharmaceuticals (Series B)Therapeutics (Seed)Therapeutics (Series A)Pharmaceuticals (Series B)Pharmaceuticals (Series A)Pharmaceuticals (Seed)BioTech (Series B)Therapeutics (Seed)Pharmaceuticals (Seed)Pharmaceuticals (Series A)BioTech (Series A)Pharmaceuticals (Series B)Pharmaceuticals (Seed)BioTech (Series B)BioTech (Seed)Pharmaceuticals (Series A)BioTech (Series B)BioTech (Series A)BioTech (Seed)BioTech (Series A)New York CityBioTech (Seed)San Francisco Bay Area
Dan Becker's Investments On Record (9)
Company | StageDateRound Size | Total Raised |
---|---|---|
Mariana Oncology | Series BSep 2023$180M Series ADec 2021$75M | $250M |
Hemab | Series BFeb 2023$140M | $140M |
Zurp | Pre SeedJan 2023$5M | $5M |
ACELYRIN | Series CSep 2022$300M | $560M |
Curie Therapeutics | Series ADec 2021$75M | $75M |
DTx Pharma | Series BMar 2021$100M | $110M |
Day One Biopharmaceuticals | Series BFeb 2021$130M Series AMay 2020$60M | $190M |
Pandion Therapeutics | Series BApr 2020$80M | $140M |
Investors who invest with Dan Becker
Scouts & Angels Affiliated With Dan Becker